AVM, B., CW, D., KE, v. S., JP, d. B., A, N., CP, L., . . . CL, Z. (2024). Treatment-related hearing loss in weekly versus triweekly cisplatin chemoradiation for head and neck cancer. European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 281(12), 6627. https://doi.org/10.1007/s00405-024-08880-x
Chicago Style (17th ed.) CitationAVM, Burger, et al. "Treatment-related Hearing Loss in Weekly Versus Triweekly Cisplatin Chemoradiation for Head and Neck Cancer." European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery 281, no. 12 (2024): 6627. https://doi.org/10.1007/s00405-024-08880-x.
MLA (9th ed.) CitationAVM, Burger, et al. "Treatment-related Hearing Loss in Weekly Versus Triweekly Cisplatin Chemoradiation for Head and Neck Cancer." European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, vol. 281, no. 12, 2024, p. 6627, https://doi.org/10.1007/s00405-024-08880-x.
